A major new study has identified specific genetic risk factors for ADHD. The findings can have significant implications for the diagnosis, prognosis and treatment of ADHD.
A number of studies over the past several years have suggested that certain types of chronic pain and ADHD may be highly correlated. The good news is there is some indication that medications and cognitive behavioral therapy used as part of an ADHD treatment plan may also provide relief for chronic pain symptoms.
New research conducted in the United Kingdom and Taiwan lends more credence to the idea that Omega-3 fish oil supplements can improve the attention of children with ADHD as much as conventional drug treatments when they have low blood levels of omega-3. This could lead to more personalized ADHD treatments incorporating nutritional supplements.
A new study shows there is a significant rise in the diagnosis of ADHD in adults. It confirms a growing recognition in the medical community that ADHD is not a condition that individuals necessarily grow out of when they become adults. The implications are significant as a diagnosis of adult ADHD is linked to a near 13-year reduction of estimated life expectancy.
Recent research conducted at Florida International University has estimated that on average, families of kids with ADHD spent $15,036 per child—not including medication or therapy—and families of kids without ADHD spent $2,848 over the course of a child’s development. The study aims to alert parents to the importance of early diagnosis and treatment to help reduce the impact on the family.
Many studies have confirmed that teen drivers with ADHD are at greater risk for being involved in an accident, getting ticketed for a traffic violation, or having their driver’s license suspended. A new study, conducted by Arunima Roy, PhD, of the University of Ottawa’s Royal’s Institute of Mental Health Research in Ontario, has found that individuals whose childhood ADHD persists into adulthood also appear to be at increased risk for motor vehicle crashes.